drugset / Trial / NCT01171391
VA106483 Dose Response in Females
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to describe the pharmacokinetics and pharmacodynamics of VA106483 in female subjects.
Timeline
- Start
- 2010-07
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VA106483 | Small molecule | 4 mg | Intravenous |
Indications
No indication recorded.